mirtazapine has been researched along with Disease Exacerbation in 7 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with mirtazapine, mefloquine and cidofovir did not affect the progression of the disease, which was fatal within 7 months of presentation." | 1.48 | Progressive multifocal leukoencephalopathy in the absence of immunosuppression. ( Stacpoole, SRL; Zucker, BE, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Sangal, RB | 1 |
| Ivgy-May, N | 1 |
| Scholten, P | 1 |
| Kralt, P | 1 |
| Jacobs, B | 1 |
| Zucker, BE | 1 |
| Stacpoole, SRL | 1 |
| Di Pauli, F | 1 |
| Berger, T | 1 |
| Walder, A | 1 |
| Maier, H | 1 |
| Rhomberg, P | 1 |
| Uprimny, C | 1 |
| Steurer, M | 1 |
| Stockhammer, G | 1 |
| Meister, S | 1 |
| Benecke, R | 1 |
| König, FB | 1 |
| Großmann, A | 1 |
| Zettl, UK | 1 |
| Winkelmann, A | 1 |
| Lutz, M | 1 |
| Schulze, AB | 1 |
| Rebber, E | 1 |
| Wiebe, S | 1 |
| Zoubi, T | 1 |
| Grauer, OM | 1 |
| Keßler, T | 1 |
| Kerkhoff, A | 1 |
| Lenz, G | 1 |
| Berdel, WE | 1 |
7 other studies available for mirtazapine and Disease Exacerbation
| Article | Year |
|---|---|
Efficacy and safety of esmirtazapine in adult insomnia: unsupported statements about residual daytime effects.
Topics: Adult; Disease Progression; Humans; Hypnotics and Sedatives; Mirtazapine; Sleep; Sleep Initiation an | 2021 |
Residual daytime effects of esmirtazapine.
Topics: Disease Progression; Double-Blind Method; Humans; Mirtazapine; Sleep Initiation and Maintenance Diso | 2021 |
Posterior fossa progressive multifocal leukoencephalopathy: first presentation of an unknown autoimmune disease.
Topics: Adrenergic alpha-Antagonists; Cerebellar Ataxia; Disease Progression; Dysarthria; Fatal Outcome; Hum | 2017 |
Progressive multifocal leukoencephalopathy in the absence of immunosuppression.
Topics: Aged; Alien Limb Phenomenon; Cidofovir; Disease Progression; Fatal Outcome; Female; Humans; Immunoco | 2018 |
Progressive multifocal leukoencephalopathy complicating untreated chronic lymphatic leukemia: case report and review of the literature.
Topics: Cytarabine; Disease Progression; Female; Humans; JC Virus; Leukemia, Lymphocytic, Chronic, B-Cell; L | 2014 |
Progressive multifocal leukoencephalopathy in a patient with pre-clinical primary biliary cirrhosis.
Topics: Aged; Brain; Disease Progression; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifo | 2014 |
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia.
Topics: Adenine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Disease | 2017 |